When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MREO - Mereo Bio's navicixizumab Fast Track'd for ovarian cancer; shares up 6% premarket
Mereo BioPharma Group
Thinly traded nano cap Mereo BioPharma Group (NASDAQ:MREO) is up 6% premarket on increased volume, albeit on turnover of only 29K shares, in reaction to Fast Track designation in the U.S. for Phase 1-stage bispecific antibody navicixizumab for heavily pretreated patients with high grade ovarian, primary peritoneal or fallopian tube cancer who have received at least three prior lines of therapy and/or prior treatment with Roche's Avastin (bevacizumab).
More news on: Mereo BioPharma Group plc, Healthcare stocks news, Stocks on the move,